Affinity Solid Supports for Oligonucleotide Extraction Without Chaotropes

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing nucleic acid sample preparation methods involve the use of cartridges with buffers containing substances like PEG and guanidine, which can co-elute into the final detection reaction, affecting efficacy, and lack control over filter material properties, leading to manufacturing complexity and cost.

Innovation Solution

The use of a solid support modified with a functional surface group and an affinity reagent, allowing for customizable interaction with nucleic acids through covalent or non-covalent bonding, and a linker for solubility enhancement, enabling efficient nucleic acid isolation and detection without chaotropic agents.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If cartridges with buffers containing PEG and guanidine are used for nucleic acid isolation, then nucleic acid binding capacity is improved, but harmful substances co-elute into the final detection reaction affecting efficacy

Engineering Contradiction:
Improvenucleic acid binding capacityVSAvoidco-elution of chaotropic substances
Core Design Contradiction:
Quantity of substanceVSObject-generated harmful factors

Solution Approach 1:

The patent extracts and removes the harmful chaotropic substances (PEG, guanidine) from the isolation buffer system, replacing them with a solid support-based capture mechanism that binds nucleic acids without requiring these harmful additives in the eluate

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces a solid support with affinity reagents as an intermediary between the sample and the detection system, which selectively captures nucleic acids through covalent or non-covalent interactions while excluding harmful substances from the final eluate

Inventive Principle:
Principle #24Intermediary (Mediator)

2Manufacturing precision

If solution-phase or gas-phase methods are used to prepare filter material, then control over surface properties is achieved, but manufacturing complexity and cost increase

Engineering Contradiction:
Improvecontrol over surface propertiesVSAvoidmanufacturing complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent changes the approach from modifying surface chemistry through complex solution-phase or gas-phase methods to a simpler solid support functionalization approach, where the solid support is treated with affinity reagents under controlled conditions to achieve desired surface properties

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite structure combining a solid support with affinity reagents (proteins, peptides, or other binding molecules), allowing control over surface properties through the selection and density of these reagents rather than through complex bulk material synthesis

Inventive Principle:
Principle #40Composite materials

3Reliability

If affinity reagents with specific binding moieties are used, then selectivity for nucleic acids is improved, but device complexity increases

Engineering Contradiction:
Improveselectivity for nucleic acidsVSAvoidaffinity reagent structure
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent designs a universal solid support platform that can be functionalized with different affinity reagents (proteins, peptides, or other binding molecules) to achieve selective nucleic acid binding, allowing the same basic structure to serve multiple functions with different selectivity requirements

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach provides enhanced control over nucleic acid isolation, reduces manufacturing complexity, and eliminates the need for costly buffer substances, while maintaining high detection accuracy.

Implementation Method 1

The functional surface group can interact with the first moiety of the affinity reagent covalently (e.g., a click/SPAAC reaction)

Methodology Applied
Scientific EffectCovalent bonding: Chemical Bonding

Implementation Method 2

or non-covalently (e.g., a charged interaction such as ionic bonding or polar interaction, hydrophobic or van der Waals interactions, a biotin-streptavidin interaction)

Methodology Applied
Scientific EffectNon-covalent bonding: Chemical Bonding

Implementation Method 3

The affinity reagent can further comprise a linker that interacts with a solvent and increases solubility of the affinity reagent

Methodology Applied
Scientific EffectSolubility enhancement: Solvation

Implementation Method 4

The affinity reagent comprises a first moiety that interacts with the solid support and a second moiety that interacts with nucleic acid in the sample

Methodology Applied
Scientific EffectAffinity binding: Adsorption

Data Source

PatentUS20250297303A1Compositions and methods for selective extraction of oligonucleotides from complex matrices
Publication Date: 2025.09.25 CEPHEID INC
  • US20250297303A1 patent drawing
  • US20250297303A1 patent drawing
  • US20250297303A1 patent drawing

AI summary

Compositions and methods for isolating and detecting nucleic acid in a biological sample are provided. The compositions and methods utilize a solid support and an affinity reagent for isolating and detecting the nucleic acid.